6th Annual Clinical Trials Summit 2015
Offering our customers the knowledge and connections for a profitable business
Speakers
  • Deepak Sawhney

    Deepak Sawhney Lambda

  • Kiran Marthak

    Kiran Marthak Lambda

  • Sowmyanarayan Srinivasan

    Sowmyanarayan Srinivasan Accenture

  • Richard Young

    Richard Young Medidata (UK)

  • Vandana Jolad Shivangi

    Vandana Jolad Shivangi VIaTAL Pharma Consulting

  • Piyush Gupta

    Piyush Gupta GNH India

  • Shehnaz Vakharia

    Shehnaz Vakharia ADAMAS Consulting APAC

  • Babita Kirodian

    Babita Kirodian Bristol Myers Squibb

  • Deepti Sanghavi

    Deepti Sanghavi SIRO Clinpharm

  • Milind Antani

    Milind Antani Nishith Desai Associates

  • V.K. Sharma

    V.K. Sharma Unichem Laboratories

  • Sujay Salvi

    Sujay Salvi SIRO Clinpharm

  • Mazhar Maruf

    Mazhar Maruf Glenmark

  • Jyotsna Patwardhan

    Jyotsna Patwardhan Novartis

  • Pratik Shah

    Pratik Shah Astellas Pharma

  • Sunit Maity

    Sunit Maity Theramyt Novobiologics

  • Chirag Trivedi

    Chirag Trivedi Sanofi Aventis

  • Kedar Suvarnapathaki

    Kedar Suvarnapathaki Boehringer Ingelheim

  • Ashwani Pandita

    Ashwani Pandita Glenmark

  • Bhaswat S. Chakraborty

    Bhaswat S. Chakraborty Cadila

  • Arun Bhatt Clininvent Research

  • K. Bangarurajan DCGI

28th & 29th May 2015, Kohinoor Continental Hotel, Mumbai, India

A critical guide for successfully conducting clinical trials

Sponsors & Exhibitors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Sponsors
  • Conference Info
  • Day One
  • Day Two
  • Speakers
  • Sponsors
  • Partners
  • Sponsorship Opportunity
  • Delegates
  • Pricing
  • Venue
  • Testimonials
  • Presentations
  • Gallery

CONFERENCE INTRODUCTION:-

The International Registry of Clinical trials, the data bank maintained by the NIH in U.S. (clinical trials.gov), has around 203,394 trials being carried out worldwide. As per this registry, the number of trials carried out in India is only 3043, which is <1.5 % of global trials. The Indian registry set up under the aegis of WHO and the Indian Council of Medical Research (ICMR) in 2T008 which made registration of all trials mandatory from June 15th of 2009 also corroborates this number. Understandably > 40 % of all global trials are carried out in the U.S. China has registered 17198 trials (> 8%) , substantially higher than India. The fear that there is an avalanche of trials moving out to India ,risking our population to trial drugs is thus unfounded. As of now India is by no means a preferred hub for clinical trials, but the the potential to become one, in view of many favourable factors, such as state-of-the-art skills of investigators, level of quality healthcare institutions, the availability of patient populations with diverse genetic pools, language advantage and information technology based analytical tools.

The events of the last two years which severely affected the clinical trial scenario in India may have even consolidated and tightened the system to bring in more transparency and quality assurance which will enhance the credibility of Indian efforts in the area. What is required is a systematic, time bound regulatory evaluation and approval system for all phases of trials and better and transparent communication between the stake holders and the regulatory agency. Without new drugs discovery, much of the disease problems of the world will remain unattended and neglected. The new government, in one of its early policy statements had emphasized the need to encourage properly conducted clinical trials in India with appropriate regulatory controls. It is fervently hoped that realising the importance of this segment in New Drug Discovery Research, the concerned authorities will take a pragmatic view and through time bound and more diligent approval processes encourage clinical research.

6th annual clinical trials summit 2015 will examine the current issues faced in clinical trials operations, addressing the risks, timeline and budget stipulations, while effectively tackling key challenges in overcoming trials agreement and site contract arbitration problems. This summit will discuss the operational element of trial site management, strategic partnership with CROs and SMOs, patient, talent &investigators management in order to improve & optimize the overall drug development effectiveness and ROI. This conference will be shared by leading industrial practitioners across the region to promote practical discussions; especially on the know-how to manage needs, variability of different countries and institutions to enhance clinical operational excellence and vigilance. Attendees will have the chance to learn, network and benchmark against the global top pharmas and local industry leaders on the best practices in talent, site, budget and performance management in clinical trials. The conference aims to provide a detailed analysis of what it takes to conduct clinical trials from a biopharmaceuticals and vaccines perspective in India and also addressing risk/benefit balance, anecdotal experiences of the multinational pharmaceutical industry in India and other parts of Asia, selection and role of CROs, logistics of operations, clinical trials management, government policies and pharmacovigilance. 6th annual clinical trials summit 2015 will provide you with the data that you need to recognize this complex and rapidly expanding sector. Knowing the future market, and what impacts will that has on future business opportunities? This is your opportunity to stay ahead by learning the latest trends and networking with the trendsetters.

It gives us immense pleasure in welcoming you to the 6th Annual Clinical Trials Summit 2015. I wish and pray that all our efforts will be beneficial to our industries and to our country at large

KEY THEMES DISCUSSED IN THIS CONFERENCE:-

  • Update yourself with respect to terms of legislation, policies, systems, technology, communication strategies and best practices
  • Determining the steps and strategies for enhancing quality in healthcare
  • Discovering the new trends in global clinical trials and their role in India
  • Technologies that drive efficiencies in global clinical trials
  • Strategies to conduct successful interventional oncology trials in India
  • Quality by design
  • Monitoring, managing and leading clinical trials: An integrated approach for better trial success
  • Maintaining proper balance in relationships: Sponsor – Site – CRO & Patients
  • Margin of safety: Identifying ideal clinical sites and strategizing patient recruitment and clinical sites management in India to develop appropriate clinical studies
  • Effectively incorporating GCP & GCPs – Knowing what TO-DO and what NOT TO-DO
  • Re-Thinking patient recruitment and patient experience
  • Finding the ideal partner in outsourcing your logistics operations in India how to identify smart packaging solutions to balance quality and costs
  • Identifying the decision criteria for partnering with the right vendors in Asia
  • How to manage risks in clinical trials effectively and how to successfully incorporate risk sharing models in clinical trials
  • Avoiding mistakes in data collection and ensuring profitability and to understand the long term operation strategies for managing clinical trials.
  • Overcoming challenges faced in regulatory approval processes – obtaining drug/ clinical supplies import and export licenses in Asia
  • Regulatory review at the drugs controller general of India (DCGI) and central drugs standard control organization (CDSCO): science, quality, and speed
  • Analyzing the recent government rules and guidelines
  • Next generations of clinical trials – How big will the market be?
  • Be part of a major networking opportunity

TARGET AUDIENCE – INDUSTRY:-

VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:

  • Pharmaceutical organizations
  • Generic pharmaceutical companies
  • Contract research organizations
  • Patient recruitment companies
  • Government - Department of health
  • Non-profit organizations/ Association
  • Consultants

WHO SHOULD ATTEND:-

CEO's, CTO's, CIO's, Presidents, Vice Presidents, Directors Heads & Managers of:

  • Clinical Research & Development
  • Clinical Research Services
  • Clinical Operations
  • Clinical Data Management
  • Clinical IT
  • Clinical Trials
  • Medical Affairs
  • Regulatory Affairs
  • Compliance
  • Quality control / Assurance/GCP
  • Clinical Study Design
  • Safety Surveillance
  • Subject Recruitment
  • E-Clinical Systems

WHY SHOULD YOU ATTEND?

6th Annual Clinical Trials Summit 2015 - “A critical guide for successfully conducting clinical trials”

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors. Expand your knowledge of the latest business models and strategies in the high-level conference, showcasing the products of tomorrow in the co-located exhibition.

08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.

09:30 – Chairperson opening remarks

V.K. Sharma, Associate Vice President, Unichem Laboratories

MARKET OVERVIEW & ANALISYS

09:40 – Morning Keynote Address 1 - Indian clinical trials: Current challenges and future focus

  • Evolving Indian Regulatory scenario
  • Challenges to India's potential in clinical research
  • Focussing the future on fundamentals

Arun Bhatt, President, Clininvent Research

10:10 – Morning Keynote Address 2 - Oncology trials in India: Opportunities and Challenges

  • India as a center for oncology trials
  • Opportunities for patients and care givers
  • Challenges associated with oncology trials

Deepak Sawhney, Associate Vice President – Late Phase Clinical Trials India, Lambda

10:40 – Morning Coffee/Tea & Discussion

CHALLENGES & OPPORTUNITIES

11:00 – Keynote Panel Discussion: Challenges and Opportunities for now and future

  • What are the current problems faced in today’s market and how to successfully overcome them in this highly competitive market?
  • Which emerging markets are hottest today?
  • Offshoring - Balancing the right opportunities and risks
  • What makes each market unique and how do markets compare?
  • Successful budget development & analysis - How do sponsors develop study budgets? How do sites price their services?
  • Recruitment and retention of patients

Moderator:

V.K. Sharma, Associate Vice President, Unichem Laboratories

Panellists:

Bhaswat S. Chakraborty, Senior VP, R&D, Cadila

Sunit Maity, AVP Product Development, Theramyt Novobiologics

Richard Young, Vice President, EMEA, Medidata (UK)

RMP

11:40 – Risk based approach

  • Onsite and remote monitoring approaches
  • Recurrent risks and mitigation through monitoring
  • Quality-by-design
  • Risk management and risk minimization
  • Risk minimization effectiveness measurement

Richard Young, Vice President, EMEA, Medidata (UK)

12:10 – Busting Myths - Comparator sourcing from India

  • Common myths, Common assumptions
  • How sourcing mistakes escalate sourcing costs and delay trials
  • Regulatory Facts for innovator registrations in India
  • Take an informed decision - Based on facts
  • Role of Specialized Comparator suppliers

Piyush Gupta, Associate Director, GNH India

12:40 - Networking luncheon

SPONSOR – SITE – CRO - PATIENTS

14:00 – Afternoon Keynote Panel Discussion - Maintaining proper balance in relationships: Sponsor – Site – CRO & Patients

  • Four-way relationship between sponsors, sites, CROs & patients - Realistic expectations, clear communications, shared understandings, practical policies, and efficient problem resolution
  • Quantitative analysis reveals rapid changes in the industry and trends for the future. How can sponsors, sites and CROs meet the challenges?
  • Choosing a partner who can take necessary steps to rectify the situation when things go wrong
  • Understanding sponsors principle for selecting the local clinical research organization
  • Identifying the anticipated advantages of a collaborative clinical trial alliance for greater efficiency and cost reduction
  • What are the current perspectives on the future of outsourcing in Asia?

Moderator:

Vandana Jolad Shivangi, Director, VIaTAL Pharma Consulting

Panellists:

Kiran Marthak, Director - Head Global Clinical Development, Lambda

Ashwani Pandita, Head Quality Management and Training, Global Clinical Research Operations, Glenmark

Sujay Salvi, Head, Clinical Trial Supplies Management, SIRO Clinpharm

QUALITY - SAFETY - SIGNAL DETECTION

14:40 - Panel Discussion - Quality and Safety Considerations in Clinical Development

  • Updates in drug safety requirements
  • Perspectives of different stakeholders on quality and safety considerations
  • Emerging trends and best practices for maintaining good quality

Moderator:

Deepti Sanghavi, Senior Medical Writer-Medical Writing, SIRO Clinpharm

Panellists:

Chirag Trivedi, Director & Head of Clinical Study Unit, Sanofi Aventis

Pratik Shah, Head- Clinical, Medical & Regulatory Affairs, PV and QA, Astellas Pharma

Jyotsna Patwardhan, Head Development QA,Novartis

Shehnaz Vakharia, Director, ADAMAS Consulting APAC

15:30 – Afternoon Tea/Coffee

REGULATORY

15:50 – Panel Discussion: The developing regulatory framework in advanced and developing markets – for Today & Tomorrow

  • Adapting to India’s transformed regulatory landscapes to conduct clinical trials
  • A brief recap of recent regulatory developments. Ensuring you comply with market requirements
  • What is to be learnt on how Indian companies can work in harmony with the RoW legal frameworks
  • Effectively incorporating GCP & GCPs – Knowing what TO-DO and what NOT TO-DO

Moderator:

Milind Antani, Partner In-Charge - Pharma LifeSciences, Nishith Desai Associates

Panellists:

K. Bangarurajan, Dy. Drugs Controller (I) CDSCO, DCGI

Mazhar Maruf, Regional Head of Pharmacovigilance- Asia Pacific, Glenmark

Kiran Marthak, Director - Head Global Clinical Development, Lambda

Kedar Suvarnapathaki, Head - Regulatory Affairs, Boehringer Ingelheim

Babita Kirodian, Head of Country Pharmacovigilance, Bristol Myers Squibb

16:50 - Chairperson’s closing remarks and end of conference

17:00 – 18:00 - Networking Drinks Session

09:00 - 10:15 - Coffee/Registration

10:15 - 10:30 - Welcome Remarks

Kyle Davids, Regional Account Manager, Medidata Solutions

10:30 - 11:15 - Keynote: An Indian Regulatory Update

Bhaswat S. Chakraborty, Senior VP & Chair, Research & Development Core Committee, Cadila

11:15 - 12:00 - Presentations: Digital revolution from patient engagement through operations

Sowmyanarayan Srinivasan, Managing Director - Life Sciences, Accenture

12:00 - 13:00 - Networking luncheon

13:00 - 13:15 - Presentations: Intro of the Medidata platform

Andrew Gebbie, Solution Consultant, Medidata Solutions

13:15 - 14:30 - Presentations: RBM Improving quality whilst reducing cost!

Christopher Burke, Product Specialist, Medidata Solutions

Andrew Gebbie, Solution Consultant, Medidata Solutions

14:30 - 15:00 - Presentations: Medidata Patient Cloud

Andrew Gebbie, Solution Consultant, Medidata Solutions

15:00 - 15:15 - Wrap-up

Kyle Davids, Regional Account Manager, Medidata Solutions

Deepak Sawhney

Associate Vice President Late Phase Clinical Trails India

Lambda

Kiran Marthak

Director - Head Global Clinical Development

Lambda

Sowmyanarayan Srinivasan

Managing Director - Life Sciences

Accenture

Richard Young

Vice President, EMEA,

Medidata (UK)

Vandana Jolad Shivangi

Director

VIaTAL Pharma Consulting

Piyush Gupta

Associate Director

GNH India

Piyush Gupta, MBBS, MBA, is an Associate Director at GNH India, since November 2009. Here he is responsible for exports to RoW (Rest of the World) Markets covering over 180 countries globally.

Main lines of business for GNH India are Clinical Trial supplies, Branded lines, Generics and hospital supplies.

Previously, he was the Director for Emerging Markets at Indigene Pharmaceuticals Inc., US. Dr. Gupta was responsible for establishing business presence in world markets like CIS, Middle East, Europe and Asia Pacific.

Dr. Gupta is a Council Member at GLG (Gerson Lehman Group) USA for their healthcare practise and advices investment bankers on Indian markets for the group.

With over 13 years of experience in Pharmaceutical Business, International Sales and Marketing, Business Development, Distribution Management across industry verticals for product categories like Patented Rx, Branded Generics, Bio-similars, Biotech, Pre-Rx, Consumer products, FMCG products and medical devices.

Shehnaz Vakharia

Director

ADAMAS Consulting APAC

Babita Kirodian

Head of Country Pharmacovigilance

Bristol Myers Squibb

Deepti Sanghavi

Senior Medical Writer-Medical Writing

SIRO Clinpharm

Milind Antani

Partner In-Charge - Pharma LifeSciences

Nishith Desai Associates

V.K. Sharma

Associate Vice President

Unichem Laboratories

Sujay Salvi

Head, Clinical Trial Supplies Management

SIRO Clinpharm

Mazhar Maruf

Regional Head of Pharmacovigilance- Asia Pacific

Glenmark

Jyotsna Patwardhan

Head Development QA

Novartis

Pratik Shah

Head- Clinical, Medical & Regulatory Affairs, PV and QA

Astellas Pharma

Sunit Maity

AVP Product Development

Theramyt Novobiologics

Chirag Trivedi

Director & Head of Clinical Study Unit

Sanofi Aventis

Kedar Suvarnapathaki

Head - Regulatory Affairs

Boehringer Ingelheim

Ashwani Pandita

Head Quality Management and Training, Global Clinical Research Operations

Glenmark

Bhaswat S. Chakraborty

Senior VP & Chair, Research & Development Core Committee

Cadila

Dr. Bhaswat S. Chakraborty graduated with a B.Pharm. (Hons.) from Banaras Hindu University and a PhD in Clinical Pharmacology from University of Saskatchewan.

Following his post doctoral fellowship and a brief spell of teaching at University of Saskatchewan, Saskatoon, Canada, Dr. Chakraborty joined the Health Protection Branch, Ministry of Health, Government of Canada (Canadian FDA) in Ottawa and served as a Senior Clinical Reviewer and Acting Department Head of the New Drug Applications.  In this role, he has evaluated more than 300 Abbreviated New Drug Applications and 20 Pharmacokinetics based New Drug Applications.

Thereafter, he was the Director of Biopharmaceutics at Biovail Corporation International, Toronto.  Till date, he has designed and investigated ~624 Phase I and 62 higher Phase Clinical Studies for the FDA, TPP, EU and other Agencies.

Recipient of many prestigious research grants, Dr. Chakraborty is currently the Senior Vice President and Chairman of Research & Development Science Core Committee at Cadila Pharmaceuticals Ltd., Ahmedabad. He is also an author and co-author of more than 100 scientific papers and abstracts in refereed international journals.

An eminent speaker, Dr. Chakraborty is an Honorary Professor and External Examiner to a few universities; editorial board member of three international journals; reviewer of many professional journal manuscripts, and also on the board of several Institutes and Universities in India and USA in various capacities. He has supervised 24 Masters’ and 5 PhD students.

Arun Bhatt

President,

Clininvent Research

K. Bangarurajan

Dy. Drugs Controller (I) CDSCO

DCGI

ORGANISED BY

Virtue Insight

Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.

GOLD SPONSOR

Medidata

We provide innovative clinical development solutions that safely and efficiently improve quality of life. We provide our customers with a competitive advantage by facilitating operational excellence in their clinical research processes:

  • Eliminating redundant and error-prone processes
  • Fostering collaboration via dynamic information flow between traditional trial   design, planning, execution and analysis silos
  • Increasing study execution agility through insightful decision-making
  • Maximizing value to sites and sponsors by supporting a best-in-class solution approach

GNH India

GNH India - A Global Full line Pharmaceutical Wholesalers with over 135,000 Product lines, supplying to over 180 countries World wide.

Specialising in Clinical Trial Supplies, Comparator supplies, Rescue Medication, Adjuvant therapeutics, Shortages, Hard to find lines, Hospital lines and Named Patient lines.

Operating from a WHO cGDP compliant warehouse with a well trained staff, under supervision of an on site QP.

Key advantages when working with GNH India:

  • Complete, audit-able paper trail to manufacturer
  • Shortest Pedigree to manufacturers
  • 21 CFR part 11 compliant Temperature monitoring and inventory management softwares
  • Validated Shipping systems
  • Counterfeit and fake prevention systems in place to maintain supply chain integrity
  • Instant availability of most drugs, including hard to find and name patient lines

Partner with a team of Pharma industry professional, partner with GNH India for all your requirements from India.

Lambda

Lambda Therapeutic Research is a leading full service CRO in the Clinical research domain. Headquartered in Ahmedabad (India), its global footprint encompasses strategically located offices in Mumbai (India), Poland (Europe), London (UK), USA and Canada (North America)

Since its inception in 1999, Lambda has grown both organically and inorganically and has gone on to establish a truly global presence. Its prime locations world-wide ensure ground level support in addition to easy access to a competent blend of human expertise and state-of-the-art infrastructure in the most efficient yet cost effective way. Lambda has BA/BE and Phase 1 facilities in India, Poland and Canada helmed by dedicated and experienced teams. It has recently commissioned Bio Analytical and Clinical Laboratory facilities and established a Business Development office in London (UK).

Lambda’s global infrastructure comprises of an impressive tally of 600+ clinical beds dedicated to Phase I clinical studies and bioequivalence studies. It has conducted more than 4800 Phase l, bioavailability / bioequivalence and/or drug-interaction studies of over 300 different chemical entities. Lambda’s database of adult male and female volunteers now exceeds 100,000 on a global level.

Lambda has extensive experience of conducting clinical studies in subjects of diverse sub groups, such as healthy and post menopausal female populations in addition to healthy male subject populations. It has conducted studies for its clients, for several regulatory agencies including ANVISA-Brazil, EMEA (Germany, Netherlands, France and other EU member state), UK-MHRA, TGA-Australia, AGES, TPS-Canada, USFDA and WHO. Since its inception, Lambda’s world-class facilities have consistently and successfully passed regulatory inspections by regulatory agencies such as DCGI, USFDA, ANVISA-Brazil, MHRA, Health Canada, AFSSAPS, Turkish-MoH and WHO.

WORKSHOP SPONSOR

Medidata

We provide innovative clinical development solutions that safely and efficiently improve quality of life. We provide our customers with a competitive advantage by facilitating operational excellence in their clinical research processes:

  • Eliminating redundant and error-prone processes
  • Fostering collaboration via dynamic information flow between traditional trial   design, planning, execution and analysis silos
  • Increasing study execution agility through insightful decision-making
  • Maximizing value to sites and sponsors by supporting a best-in-class solution approach
KNOWLEDGE SPONSOR

Nishith Desai

EXHIBITOR

Piramal Healthcare

Piramal Pharma Solutions is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end services required to bring a drug to the market place faster. We offer Pharmaceutical Development and Manufacturing solutions through collaborative partnership models and we work with our customers throughout the drug life cycle.

We have created a vast network of Development and Manufacturing facilities located in North America, Europe and Asia that offers a multitude of services covering the entire drug life cycle, from Drug Discovery & Development to Commercial Manufacturing of off-patent Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). Our capability as an integrated service provider & experience with various technologies enables us to serve Innovator and Generic companies worldwide.

Our Development centers & Manufacturing sites have accreditations from regulatory bodies in US, Europe & Japan. With a pool of 450 scientists, including 100 Ph.d’s across the Globe we are committed to Research & Development programs. We offer specialized services such as Antibody Drug Conjugation and are well versed in technologies such as Bio-catalysis.

At Piramal Solutions, we are moving towards becoming a ‘Customer Centric’ organization by focusing on the “Pulse of the Customer”. We are evaluating various ways to improve our internal processes, communications, and program management in order to improve our delivery commitments and service levels.

This division features among the top 10 contract drug manufacturers in the world as per report released by UN Conference on Trade and Development and recently in March 2014 we won two awards for “Quality” and “Reliability” in the CRO/CMO by Life Science Leaders.

PDP Courier

PDP Couriers is a truly global specialist courier for clinical trials, transport of clinical and medical research and logistics management. It is  the number one choice for Clinical Trial Project Managers,  logistics consultants and healthcare professionals, offering them solutions for time critical and temperature sensitive shipments for pre-clinical trials and phase I – IV clinical trial material.

Customers value PDP's experience and reliability with over 20 years of success in international courier services and transport of clinical trials and clinical research materials. PDP has built trust with its customers for its proven ability as a logistics specialist to respond to the specific and challenging requirements of clinical trial logistics on a global scale.

PDP has a truly integrated worldwide operation with wholly owned offices and trained staff in all key continents. We are able to deal with local regulatory authority and customs import and export regulations.

With over 20 years’ experience and a primary focus on Clinical Research and Healthcare shipping, you can be sure that PDP Couriers has tailored a specialist courier service to meet your needs, be it shipping Active Pharmaceutical Ingredients (APIs), CHO cells and cell lines, investigational drugs, biological samples, medical research materials, cord blood samples, stem cell delivery, vaccines or commercial products.

For More Information: www.pdpcouriers.com

Almac

Almac Group is an established, leading contract development and manufacturing organizationwith a strong reputation for innovation, quality and customer service.  They provide an extensive range of integrated services to 600+biopharmacompanies globally. Their comprehensive solutions range fromR&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IRT technology (IVRS/IWRS) through to commercial-scale manufacture.The international company is a privately owned organization and has grown organically over 40 years employing in excess of 3,600 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with US operations based in Pennsylvania, North Carolina, California, Singapore and Japan.

SUPPORTED BY

Clocate

Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location.  Each event includes detailed information, like, description, dates, location, map, prices, link to the official event's  website and more...

If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you'll find it in Clocate.com

Going to meet

BusinessVibes

BusinessVibes is a global B2B networking site which is home to 600+ associations and 200,000+ companies in 92 countries worldwide.We use a social networking model to promote business partnerships between companies in the US, Europe, India, China, and other major economies.

Pharmaphorum

pharmaphorum is the primary facilitator of thought leadership and innovation within pharma. We support the next generation of pharmaceutical industry leaders through producing, curating and publishing media that will help pharma embrace the challenges of being a healthcare solutions provider in the 21st century.

Our services include:

  • Publication of interesting new written, audio and video content addressing critical pharma issues from around the world.
  • Showcasing key service providers who can work with pharma executives to forge the business models of the future.
  • Curation of global news, industry events and job opportunities within pharma.
  • Production of written, audio and video content for publication on pharmaphorum or client channels.
  • Advice and support on the use of social media within pharma to effectively connect companies, improve PR and share innovation.

Lex Witness

LEX WITNESS – India’s 1st Magazine on Legal & Corporate Affairs

LEX WITNESS vows to be a high quality monthly magazine with the powers of fresh and original content that would deal exclusively with subjects pertaining to legality. Country's top notch practitioners and experts are being invited to contribute in WITNESS with what we feel is relevant to all stakeholders in this profession, aiming at brainstorming between the legal luminaries and hence bettering this practice in all its aspects.

Reports and Reports

ReportsandReports comprises of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites.

Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.

Physis Learing Academy

Markets and Markets

MarketsandMarkets is a full service and consulting firm that produces strategically analyzed full length reports track more than 10 industries. M&M plans to launch industry-wise and country wise market tracker for all the verticals tracked. This intelligence database comprising of about 60000 reports a year will form one of the world's largest intelligence resources worldwide. MarketsandMarkets has effectively used technology to automate management of large and complex data for forecasts. MarketsandMarkets aspires to help its client to achieve sustainable growth by providing incisive business insights into their respective business partners. Our 200 global strategic accounts with topline revenues in excess of USD 1 Billion annually. Delivered syndicated research studies to top publishers globally on a subcontracting model. The major industries that we cover in our market intelligence deliverables are Pharma & Biotech, Telecom & IT, Healthcare & Life sciences, Chemical & Advanced Material, Electronics & Semiconductors and Foods & Beverages.

Partnering with Virtue Insight means more than making the right contacts. It means being an insider. It means being connected to the right people with the right level of influence, and it means you are allied with a globally respected organization and leaders in the industry.?


Sponsorship, exhibiting and advertising packages are designed to provide a solid platform to help you stand out and make an impact. Our programs allow you to achieve your marketing goals and deliver a maximum return on your investment. We have developed convenient and customizable packages to help your organization meet its objectives and reach your target market.


Why Sponsor / Exhibit:

PROFIT: To Maximize
MARKET SHARE: Defending and Increasing Market Share
COMPETITION: To attach and defend against competition


Benefits:

  • Generating sales leads
  • Build brand image
  • Maintaining customer relations
  • Consolidating business relationships
  • Accessing new and emerging markets
  • Obtaining technical knowledge
  • Leverages the events extensive marketing campaign to add value to your organisations marketing strategy and budget leading up to the event
  • Live product demonstration to test market responses
  • Facilitating quick market penetration
  • Reach important targeted commercial prospects face to face in a social, relaxed environment. The ideal platform to build strong business friendships Strengthen your market position


Our conferences offer not only a unique combination of benefits (as listed above) to enable the sponsor/exhibitor to communicate the message but also a major opportunity that other forms of selling or media cannot provide.


Contact Us Today

UK
Email - sponsor.uk@virtueinsight.com
Tel: +44-2036120886


INDIA
Email - sponsor@virtueinsight.com
Tel: +91 44 64536444


Our highly researched conference agenda delivers all the latest information and our world-class speakers attract delegates from around the world to attend. We aim for our attendees to be equipped with knowledge of latest developments and enable them to network with the industry key personnel.


What is the format of our conference programme?
The conference programme consists of world-class keynote addresses, case study presentations and panel discussions.


What are the benefits of attending?

  • Meet your peers in an interactive, discussion-based format designed to maximize knowledge transfer and networking
  • Enjoy our informal networking at drinks and lunch
  • Meet the leading solution providers in the market to forge partnerships and discover solutions
  • Receive electronic versions of the conference documentation for use of reference post-event.
  • Get ideas for?training topics?that you might want to present as professional development sessions to others in your workplace.
  • Observe speakers from the perspective of seeing what works really well so you can learn new public speaking techniques and strategies that you can apply when doing your own presentations.
  • Learn what not to do in presentations if you end up sitting through any sessions that fail to be engaging or informative.
  • Delegates also benefit from discounted rates onfuture event attendance


For more information or to register at the event please contact us TODAY:


Contact Us Today

UK
Email - delegate.uk@virtueinsight.com
Tel: +44-2036120886


INDIA
Email - delegate@virtueinsight.com
Tel: +91 44 64536444

.

Very interactive informative and time managed session

Kirti Ratolikar
Manager - QA &RA, Sanofi Pasteur

Since Pharama companies have ventured into Biologicals/ Biosimilars business, the conference could have focused on discussing case stdies in Biosimilars Clinical trails, challenges in CTS in New Biologicals& Vaccines.

Tanushree Bhattacharya
Regulatory Affairs Biologicals-Cipla New Ventures, Cipla

It was great experience attending this clinical trial summit 2015. It Learned lot of new updates in clinical trial industry as well as regulatory.

Shankaranarayanan. J
Sr. Manager Clinical Research, OmniActive Health Technologies
DOWNLOAD 6th Annual Clinical Trials Summit 2015 - Final list of attendees
DOWNLOAD Piyush Gupta, GNH India
DOWNLOAD Richard Young, Medidata Solutions
Close
Welcome
You have been registered successfully!
Close
Close
Enter Password
Submit Close